Gossypetin Derivatives are also Putative Inhibitors of SARS-COV 2: Results of a Computational Study
Open Access
- 1 October 2020
- journal article
- Published by SciRes Literature LLC
- Vol. 1 (6), 201-212
- https://doi.org/10.37871/jbres1144
Abstract
SARS-CoV-2 is the third most highly virulent human coronavirus of the 21st century. It is linked with fatal respiratory illness. Currently, there are still no effective treatments of Covid-19. Among many drugs evaluated, few have proven conclusive clinical efficacy. Furthermore, the spread of the disease mandates that ideal medications against Covid-19 be cheap and available worldwide. Therefore, there is a rationale to evaluate whether treatments of natural origin from aromatic and medicinal plants have the ability to prevent and/or treat COVID-19. We evaluated in this study the inhibition of COVID-19 protease by natural plants compounds such as Gossypetin-3'-O-glucoside (G3'G). G3'G has been isolated from the petals of Talipariti elatum Sw. found almost exclusively in Martinique. It has no crystallography or modelisation studies. Antifungal and antioxidant properties are already published. We study its binding affinity so potential inhibition capability against SARS-CoV2 3CLpro mean protease as compared to other previously tested natural or pharmacological molecules by molecular docking. We propose Gossypetin derivatives as good tropical natural compounds candidate that should be further investigated to prevent or treat COVID19.Keywords
This publication has 31 references indexed in Scilit:
- Lessons Learned in Empirical Scoring with smina from the CSAR 2011 Benchmarking ExerciseJournal of Chemical Information and Modeling, 2013
- Open Babel: An open chemical toolboxJournal of Cheminformatics, 2011
- Chemical Name to Structure: OPSIN, an Open Source SolutionJournal of Chemical Information and Modeling, 2011
- PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKaPredictionsJournal of Chemical Theory and Computation, 2011
- MetaPocket: A Meta Approach to Improve Protein Ligand Binding Site PredictionOMICS: A Journal of Integrative Biology, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculationsNucleic Acids Research, 2004
- Statistical evidence for the usefulness of Chinese medicine in the treatment of SARSPhytotherapy Research, 2004
- The Protein Data BankNucleic Acids Research, 2000